Table 2.

The levels of 8-iso-PGF2α in BALF and serum (x̅ ±s)

Group	n	BALF (ng/ml)	Serum (ng/ml)
Healthy control group	10	19.10±0.91	31.65±0.45
COPD model group	10	37.14±0.21*	40.74±6.86*
Budesonide group	10	23.50±1.01†	38.14±3.37‡
Erythromycin group	10	19.62±0.76†	28.96±0.55†
Erythromycin + budesonide group	10	19.38±0.74†,§,**	29.73±0.69†,§,**

^*Compared with healthy control group, P<0.05;

^†Compared with COPD model group, P<0.05;

^§Compared with budesonide group, P<0.05;

^‡Compared with COPD model group, P=0.435;

^**Compared with erythromycin group, P=0.621 and 0.797.